STRS Ohio’s Accelerate Diagnostics AXDX Stock Holding History

STRS Ohio’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,667	Closed	-$2.39M	–	1880
2017 Q3	$2.39M	Buy	+10,667	New	+$2.62M	0.01%	609
2015 Q3	–	Sell	-400	Closed	-$86.6K	–	1881
2015 Q2	$103K	Hold	400	–	–	﹤0.01%	1672
2015 Q1	$90K	Sell	400 -950	-70%	-$198K	﹤0.01%	1624
2014 Q4	$259K	Hold	1,350	–	–	﹤0.01%	1384
2014 Q3	$290K	Sell	1,350 -60	-4%	-$11.7K	﹤0.01%	1368
2014 Q2	$367K	Buy	1,410 +980	+228%	+$214K	﹤0.01%	1307
2014 Q1	$94K	Hold	430	–	–	﹤0.01%	1555
2013 Q4	$52K	Sell	430 -50	-10%	-$6.68K	﹤0.01%	1639
2013 Q3	$64K	Hold	480	–	–	﹤0.01%	1700
2013 Q2	$39K	Buy	+480	New	+$35.6K	﹤0.01%	1760

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

STRS Ohio's AXDX Position: Q4 2017 in Review

STRS Ohio sold out of Accelerate Diagnostics (AXDX) in Q4 2017, closing a stake of 10,667 shares — an estimated $2.39M sold.

STRS Ohio first reported a position in AXDX in Q2 2013 and held it in 10 quarters. The position peaked at $2.39M in Q3 2017. 118 funds tracked by Wall St. Rank hold AXDX as of Q4 2017.

STRS Ohio reported no remaining Accelerate Diagnostics position as of Q4 2017 after selling out during the quarter.
STRS Ohio sold 10,667 Accelerate Diagnostics shares in Q4 2017, an estimated $2.39M.
STRS Ohio first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 10 quarters.
STRS Ohio's Accelerate Diagnostics position peaked at $2.39M in Q3 2017.
118 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2017.

Based on STRS Ohio's 13F filing for Q4 2017, filed 23 Jan 2018.